Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 5, 2014

View Archived Issues

Capstone Therapeutics reports phase Ia results for AEM-28

Infinity Pharmaceuticals and Roche to evaluate combinations of obinutuzumab and duvelisib

Mutation type and location correlates with enzymatic abnormalities

BARDA extends contract with Chimerix for brincidofovir for treatment of smallpox

BioLineRx initiates phase I study of BL-8040 for stem cell mobilization

Development and characterization of a novel anti-influenza preclinical candidate

Group in Thailand generates novel series of multivalent HIV-1 integrase inhibitors

Trinomia polypill increases adherence to cardiovascular treatments

Cynata Therapeutics initiates EMA scientific advice procedure for Cymerus

Bristol-Myers Squibb launches two antiviral agents in Japan

Researchers in Israel disclose novel phosphorylcholine conjugates for autoimmune disease

CUNY discloses new NO- and H2S-releasing NSAIDs

Novel EZH2 inhibitors disclosed by Constellation Pharmaceuticals for cancer

Russian group synthesizes new HCV NS5A inhibitors

New ROR gamma modulators reported by Aurigene

Levomepromazine proves safe and effective for the management of distressing NEMD in MPS III

Companies commit to accelerating vaccine program in response to Ebola crisis

FDA awards pembrolizumab accelerated approval for melanoma

FDA grants fast track status to Pulmaquin for non-cystic fibrosis bronchiectasis

Chimerix's brincidofovir shows in vitro activity against Ebola

Bayer submits MAA for Eylea in Japan for macular edema following BRVO

Launch of inhaled, once-daily combination treatment for COPD in Japan

Sanofi announces Japanese launch of Jevtana for prostate cancer

FDA gives NewLink Genetics approval to conduct phase I studies of Ebola vaccine

Mapp Biopharmaceutical signs HHS contract to accelerate development of ZMapp

Merck & Co.'s relebactam earns FDA QIDP designation

FDA grants QIDP designation to Debiopharm's Debio-1450

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...